{"product_id":"bortezomib-for-injection-35-mg-powder-vial","title":"Bortezomib for Injection 3.5 mg Powder Vial","description":"\u003cp\u003eBortezomib for Injection is a powerful proteasome inhibitor used in the treatment of certain types of cancer, notably multiple myeloma and mantle cell lymphoma. This lyophilized powder, when reconstituted, delivers targeted therapy for managing complex hematologic malignancies.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eUsage:\u003c\/strong\u003e Bortezomib is indicated for the treatment of patients with multiple myeloma and those with mantle cell lymphoma who have received at least one prior therapy. It is used as part of a comprehensive cancer treatment regimen.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDosage:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStandard Dosage:\u003c\/strong\u003e Administered as an intravenous (IV) bolus injection or subcutaneous injection at a recommended dose of 1.3 mg\/m² twice weekly for two weeks, followed by a 10-day rest period (21-day treatment cycle).\u003c\/li\u003e\n\u003cli\u003eDosage may vary based on specific patient conditions and response.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCDC Guidelines:\u003c\/strong\u003e Though the CDC does not provide specific dosing guidelines for Bortezomib, it emphasizes adherence to oncological treatment protocols and monitoring for adverse effects to ensure patient safety. Proper handling and disposal of chemotherapeutic agents are also recommended.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrength:\u003c\/strong\u003e 3.5 mg per vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Lyophilized powder for reconstitution\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePackaging:\u003c\/strong\u003e 8 mL vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProteasome Inhibition:\u003c\/strong\u003e Targets and disrupts cancer cell growth\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVersatile Administration:\u003c\/strong\u003e Suitable for IV or subcutaneous use\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e Bortezomib works by inhibiting the 26S proteasome, a protein complex involved in degrading ubiquitinated proteins. This inhibition disrupts various cellular processes, leading to apoptosis in cancer cells, particularly those with high protein turnover like myeloma cells.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eReconstitute the powder with sterile saline following aseptic technique.\u003c\/li\u003e\n\u003cli\u003eAdminister via appropriate route (IV or subcutaneous) as prescribed.\u003c\/li\u003e\n\u003cli\u003eFollow specific oncologist or healthcare provider protocols closely.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePatients should be monitored for peripheral neuropathy, hematologic toxicity, and cardiac events.\u003c\/li\u003e\n\u003cli\u003eContraindicated in patients with hypersensitivity to bortezomib, boron, or mannitol.\u003c\/li\u003e\n\u003cli\u003eUse caution in patients with hepatic impairment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e Common side effects include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eFatigue\u003c\/li\u003e\n\u003cli\u003eGastrointestinal symptoms (nausea, diarrhea)\u003c\/li\u003e\n\u003cli\u003eThrombocytopenia\u003c\/li\u003e\n\u003cli\u003ePeripheral neuropathy\u003c\/li\u003e\n\u003cli\u003eFever In case of serious adverse reactions, seek immediate medical intervention.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eBortezomib for Injection by Hikma represents advanced therapeutics in cancer care, offering efficacy and flexibility in treatment regimens for healthcare professionals and patients alike.\u003c\/em\u003e\u003c\/p\u003e","brand":"Fresenius USA","offers":[{"title":"Default Title","offer_id":51718942294183,"sku":"emv1793470573334","price":17.88,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0755\/1841\/0919\/files\/bortezomib-for-injection-35-mg-powder-vial_1.jpg?v=1793470577","url":"https:\/\/ianpoolkit.shop\/products\/bortezomib-for-injection-35-mg-powder-vial","provider":"My Store","version":"1.0","type":"link"}